Data / Form D filings / Prothena Corp plc
Prothena Corp plc: Form D filing
Prothena Corp plc, a biotechnology company in Dun Laoghaire, Co. Dublin, Ireland, filed a Form D with the SEC in 2018. The latest, on March 29, 2018, reports $50 million sold of a $50 million offering to 1 investor.
Find out what Prothena Corp plc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ADELPHI PLAZA, UPPER GEORGE'S STREET, Dun Laoghaire, Co. Dublin, Ireland, A96 T
- Phone
- 011-353-1-236-2500
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Ireland
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1559053
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 29, 2018 | New notice | $49,999,997 | $49,999,997 | $0 | 1 | Mar 21, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard T. Collier | Director | |
| Tran B. Nguyen | Executive Officer | |
| Arthur W. Homan | Executive Officer | |
| Lars G. Eckman, M.D., Ph.D. | Director | |
| Dennis J. Selkoe | Director | |
| Karin L. Walker | Executive Officer | |
| Tara B. Nickerson, Ph.D. | Executive Officer | |
| Wagner M. Zago, Ph.D. | Executive Officer | |
| Christopher S. Henney, Ph.D., D.Sc. | Director | |
| Carol D. Karp | Executive Officer | |
| Shane M. Cooke | Director | |
| Anders O. Harfstrand, M.D., Ph.D. | Director | |
| Gene G. Kinney, Ph.D. | Executive Officer, Director |
Every Form D from the week of Mar 26, 2018 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Prothena Corp plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.